Met Life Investment Management, LLC Rubius Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.79 - $5.98 $14,893 - $112,734	-18,852 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$4.25 - $10.4 $80,121 - $196,060	18,852 New	18,852 $103,000
Q1 2022 Jun 20, 2023	BUY	$4.25 - $10.4 $80,121 - $196,060	18,852 New	18,852 $103,000
Q1 2022 Mar 22, 2023	BUY	$4.25 - $10.4 $8,908 - $21,798	2,096 Added 12.51%	18,852 $103,000
Q1 2022 May 12, 2022	BUY	$4.25 - $10.4 $8,908 - $21,798	2,096 Added 12.51%	18,852 $104,000
Q4 2021 Jun 21, 2023	BUY	$9.68 - $17.74 $162,198 - $297,251	16,756 New	16,756 $162,000
Q3 2021 Jun 21, 2023	BUY	$17.6 - $25.91 $294,905 - $434,147	16,756 New	16,756 $299,000
Q2 2021 May 17, 2024	BUY	$22.26 - $28.43 $54,848 - $70,051	2,464 Added 17.24%	16,756 $409,000
Q2 2021 Jun 21, 2023	BUY	$22.26 - $28.43 $372,988 - $476,373	16,756 New	16,756 $409,000
Q2 2021 Mar 22, 2023	BUY	$22.26 - $28.43 $54,848 - $70,051	2,464 Added 17.24%	16,756 $409,000
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $54,848 - $70,051	2,464 Added 17.24%	16,756 $409,000
Q1 2021 May 17, 2024	BUY	$8.02 - $32.01 $114,621 - $457,486	14,292 New	14,292 $378,000
Q1 2021 Jun 26, 2023	BUY	$8.02 - $32.01 $114,621 - $457,486	14,292 New	14,292 $379 Million
Q1 2021 Mar 22, 2023	SELL	$8.02 - $32.01 $26,441 - $105,536	-3,297 Reduced 18.74%	14,292 $378,000
Q1 2021 May 14, 2021	BUY	$8.02 - $32.01 $114,621 - $457,486	14,292 New	14,292 $379,000
Q3 2020 Nov 13, 2020	SELL	$4.65 - $6.25 $81,788 - $109,931	-17,589 Closed	0 $0
Q2 2020 May 24, 2024	BUY	$4.01 - $6.88 $70,531 - $121,012	17,589 New	17,589 $105 Million
Q2 2020 Jun 26, 2023	BUY	$4.01 - $6.88 $70,531 - $121,012	17,589 New	17,589 $105,000
Q2 2020 Mar 22, 2023	BUY	$4.01 - $6.88 $4,727 - $8,111	1,179 Added 7.18%	17,589 $105,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $6.88 $70,531 - $121,012	17,589 New	17,589 $105,000
Q1 2020 May 15, 2020	SELL	$3.74 - $9.84 $61,373 - $161,474	-16,410 Closed	0 $0
Q4 2019 Jul 12, 2023	BUY	$7.23 - $14.12 $118,644 - $231,709	16,410 New	16,410 $155,000
Q3 2019 Jul 12, 2023	BUY	$7.85 - $15.75 $128,818 - $258,457	16,410 New	16,410 $128,000
Q2 2019 Jul 12, 2023	BUY	$13.5 - $19.94 $221,535 - $327,215	16,410 New	16,410 $258,000
Q1 2019 Jul 13, 2023	BUY	$13.27 - $18.51 $217,760 - $303,749	16,410 New	16,410 $297,000
Q1 2019 Mar 22, 2023	BUY	$13.27 - $18.51 $74,696 - $104,192	5,629 Added 52.21%	16,410 $297,000
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $74,696 - $104,192	5,629 Added 52.21%	16,410 $297,000
Q4 2018 Jul 13, 2023	BUY	$13.83 - $22.97 $149,101 - $247,639	10,781 New	10,781 $173,000
Q4 2018 Mar 22, 2023	SELL	$13.83 - $22.97 $84,349 - $140,094	-6,099 Reduced 36.13%	10,781 $173,000
Q4 2018 Feb 14, 2019	SELL	$13.83 - $22.97 $84,349 - $140,094	-6,099 Reduced 36.13%	10,781 $173,000
Q3 2018 Jul 13, 2023	BUY	$20.06 - $26.94 $216,266 - $290,440	10,781 New	10,781 $258,000
Q3 2018 Mar 22, 2023	BUY	$20.06 - $26.94 $338,612 - $454,747	16,880 New	16,880 $405,000
Q3 2018 Nov 14, 2018	BUY	$20.06 - $26.94 $338,612 - $454,747	16,880 New	16,880 $405,000

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account